IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Aug 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-18

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-18	Common Stock	M	20000	$67.85	Acquired	830467	Direct
2020-08-18	Common Stock	S	3579	$382.2811	Disposed	826888	Direct
2020-08-18	Common Stock	S	4461	$383.8096	Disposed	822487	Direct
2020-08-18	Common Stock	S	4477	$384.9440	Disposed	817950	Direct
2020-08-18	Common Stock	S	7383	$385.6023	Disposed	810567	Direct
2020-08-18	Common Stock	S	100	$386.40	Disposed	810467	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-18	Non-Qualified Stock Option (right-to-buy)	$67.85	M	20000	Disposed	2026-02-13	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Represents the weighted average price of the shares sold ranging from a low of $382.11 to a high of $382.961 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average price of the shares sold ranging from a low of $383.22 to a high of $384.13 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $384.38 to a high of $385.37 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $385.39 to a high of 386.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Grant of option to buy shares of Issuer common stock exercisable in five annual installments beginning February 14, 2017.

F6: Not applicable.